Divine Skin has signed a letter of intent to acquire 100 percent of its Mexican distributor, as the company represented nearly 10 percent of the biotechnology company’s revenue in 2012.
New launches and expansions were behind Divine Skin’s successful third quarter as the company reported a revenue increase of over a third as it stays on track for a record breaking year.
Hair loss has plagued man since the dawn of time, and now Divine Skin believes it may have found the answer by releasing the first topical hair growth treatment based on astressin-B, a peptide that was discovered to regrow hair on bald mice.
US-based biotech company Divine Skin (DS) has partnered with Indian manufacturer Ranbaxy Laboratories, as it looks to offer hair growth treatments and take advantage of the pharmaceutical firm's distribution channels.
Biotechnology developer Divine Skin announced preliminary Q3 numbers today: $1.6 million or 23 percent above the previous quarter and 75 percent above Q3 of last year.
